Stig E Bojesen1, Julia S Johansen, Børge G Nordestgaard. 1. Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Denmark. stebo@heh.regionh.dk
Abstract
BACKGROUND: Plasma YKL-40 is a new biomarker in patients with cancer and inflammatory diseases. High plasma YKL-40 is associated with poor prognosis. Our aim was to determine reference levels in healthy subjects. METHODS: Plasma YKL-40 was determined in 3130 participants aged 20-80 years from the Danish general population, the Copenhagen City Heart Study. They had no known disease at time of blood sampling in 1991-1994 and remained healthy and alive during a 16-year follow-up period. In 644 participants, YKL-40 was measured again in samples taken 10 years after the first. RESULTS: The median plasma YKL-40 was 40 μg/L (2.5-97.5% reference levels: 14-155) with no difference between sexes. YKL-40 increased exponentially with age. For age-adjusted reference levels, the YKL-40 percentile as a function of age in years and plasma YKL-40 in μg/L was derived: percentile=100/(1+(YKL-40^-3)*(1.062^age)*5000). In subjects with two YKL-40 measurements 10 years apart, the mean increase in YKL-40 was 1.5 μg/L/year (SE: 0.2), while the mean change in the calculated age percentile was minimal (-0.3; SE: 0.1). CONCLUSIONS: Plasma YKL-40 increases with age within and across healthy individuals from the general population. Age-stratified or age-adjusted reference levels are important when YKL-40 test results are evaluated.
BACKGROUND: Plasma YKL-40 is a new biomarker in patients with cancer and inflammatory diseases. High plasma YKL-40 is associated with poor prognosis. Our aim was to determine reference levels in healthy subjects. METHODS: Plasma YKL-40 was determined in 3130 participants aged 20-80 years from the Danish general population, the Copenhagen City Heart Study. They had no known disease at time of blood sampling in 1991-1994 and remained healthy and alive during a 16-year follow-up period. In 644 participants, YKL-40 was measured again in samples taken 10 years after the first. RESULTS: The median plasma YKL-40 was 40 μg/L (2.5-97.5% reference levels: 14-155) with no difference between sexes. YKL-40 increased exponentially with age. For age-adjusted reference levels, the YKL-40 percentile as a function of age in years and plasma YKL-40 in μg/L was derived: percentile=100/(1+(YKL-40^-3)*(1.062^age)*5000). In subjects with two YKL-40 measurements 10 years apart, the mean increase in YKL-40 was 1.5 μg/L/year (SE: 0.2), while the mean change in the calculated age percentile was minimal (-0.3; SE: 0.1). CONCLUSIONS: Plasma YKL-40 increases with age within and across healthy individuals from the general population. Age-stratified or age-adjusted reference levels are important when YKL-40 test results are evaluated.
Authors: Insa M Schmidt; Isaac E Hall; Sujata Kale; Sik Lee; Chuan-Hua He; Yashang Lee; Geoffrey L Chupp; Gilbert W Moeckel; Chun Geun Lee; Jack A Elias; Chirag R Parikh; Lloyd G Cantley Journal: J Am Soc Nephrol Date: 2013-01-04 Impact factor: 10.121
Authors: Yang Zhou; Chuan Hua He; Erica L Herzog; Xueyan Peng; Chang-Min Lee; Tung H Nguyen; Mridu Gulati; Bernadette R Gochuico; William A Gahl; Martin L Slade; Chun Geun Lee; Jack A Elias Journal: J Clin Invest Date: 2015-06-29 Impact factor: 14.808
Authors: Jose L Gomez; Gina M Crisafi; Carole T Holm; Deborah A Meyers; Gregory A Hawkins; Eugene R Bleecker; Nizar Jarjour; Lauren Cohn; Geoffrey L Chupp Journal: J Allergy Clin Immunol Date: 2015-01-13 Impact factor: 10.793
Authors: B Kornblit; T Wang; S J Lee; S R Spellman; X Zhu; K Fleischhauer; C Müller; M R Verneris; K Müller; J S Johansen; L Vindelov; P Garred Journal: Bone Marrow Transplant Date: 2016-07-18 Impact factor: 5.483
Authors: Norihisa Nishimura; Davide De Battista; David R McGivern; Ronald E Engle; Ashley Tice; Rafaelle Fares-Gusmao; Juraj Kabat; Anna Pomerenke; Hanh Nguyen; Shinya Sato; Kevin W Bock; Ian N Moore; David E Kleiner; Fausto Zamboni; Harvey J Alter; Sugantha Govindarajan; Patrizia Farci Journal: Proc Natl Acad Sci U S A Date: 2021-04-27 Impact factor: 11.205